DatasetName,KANK2_C(427) KANK2_C(428) KANK2_C(432) KANK2_C(436) KANK2_M(375) KANK2_S(1536) KANK2_S(3) KANK2_S(5) KANK2_T(168) KANK2_T(403) KANK2_Y(360),KANK2_S(10) KANK2_S(101) KANK2_S(19) KANK2_S(249) KANK2_S(323) KANK2_S(356) KANK2_S(375) KANK2_S(406) KANK2_S(463) KANK2_S(540) KANK2_S(568) KANK2_S(580) KANK2_S(72) KANK2_S(83) KANK2_S(88) KANK2_S(92) KANK2_T(14) KANK2_T(176) KANK2_T(36) KANK2_T(573) KANK2_T(6) KANK2_T(88) KANK2_Y(100) KANK2_Y(32)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,0.5175939573376335
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,0.5134148583883338
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.4994045611306536
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,0.5101175174557602
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.5247518613834782
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.4874699636853663
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.49427580219887823
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,0.4885577833318504
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,0.48752392538714556
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,0.4812186837557871
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,0.5007827588569834
EP2017_Untreated R#4 normalized log2 ratio,0.6440470300336328,0.4817156854247559
WZ2023_Pu_010_30min,0.6541033439087093,0.5300357008834459
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5021155853582501
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,0.4973897175902043
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.5071391606578212
JJ2018_Ratio H/L normalized___1,,0.4943216061154236
ZQ2022_C2,,0.4660146971348207
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,0.499794442176505
AH2018_SILAC_MR_2_N,,0.49720627316222005
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.5121052871439384
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,0.5136046003877859
FSO2013_Ratio H/L normalized Rep2___2,,0.5076765439182428
EP2017_Pervanadate R#3 normalized log2 ratio,0.665369043950858,0.5182279162943718
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,0.5324376109549295
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.5282790374550518
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.6478677736179441,0.5270917576977315
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,0.4931693241095694
WZ2023_Pu_005_10min,0.655482573714615,0.5334646371523083
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,0.49526118026951305
WZ2023_Pu_025_30min,0.6495106143023865,0.5302907142577332
AH2018_SILAC_MR_2_X,,0.49499252499710344
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.500563762227689
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,0.5011800399079746
CR2017_Ratio Replicate 1.3,,0.5044051061702882
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.4953033066527422
JJ2018_Ratio M/L normalized pP3,,0.49811133502815474
AH2018_SILAC_M_2_N,,0.49330245022334757
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.5030715819051924
AH2018_LFQ_1_C,,0.49951809704593453
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,0.49447942437446496
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6498076647845132,0.5253958066020812
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.49152246475042255
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.5070054189042663
FSO2013_Ratio H/L normalized Rep2,,0.48120774945375633
WZ2023_Pu_005_20min,0.6500639026296959,0.5314659298994188
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.5009945265925367
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,0.5045719114609323
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.5034481609860918
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,0.49978593280903966
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,0.5008536481978605
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,0.5002884261009423
PG2020_Intensity Mock_10h_D,,0.4982277004381817
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.643310823817846,0.4852708625931928
RCJD2014_5min_1,,0.49556676249417125
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.49335405443780367
PG2020_Intensity 2h_C,,0.49232767506604036
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.5242429833889052
KBE2022_Log2_Ex_8_T,,0.49915168736591914
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,0.5336884368502773
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.4989264148114243
CK2022_3 40-1,,
RBK2021_1260T Early,,0.504445142101543
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,0.5046220399739286
HH2022_Reporter intensity 8,0.6525762684101069,
ZQ2022_N2,,0.5401308545744428
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.5042515760620239
EJN2021_5_Rest_Basal,,0.5001792829672739
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.4980001051107866
YA2020_Reporter_intensity_Normal_No.1,,0.5004243029051817
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.507829218719113
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,0.5073360310973303
RB2022_3_PostSprint,,0.5001887597097995
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.5188738672915164
HS2024_8_I_T3,,
CF2017_EOC 3,,0.5005059756991465
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.6542493673494948,0.5269953540267803
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,,0.4969522593348153
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.5039180127059759
FSO2013_Ratio H/M normalized Rep2,,0.5125214515887234
RAM2015_Log2 A,,0.5065213347747152
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,0.5048767150054391
CF2017_OSE 27,,0.5023354049761842
KS2014_Intensity E15_2,,0.5084140591031557
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.4877461030917252
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.4965680139829762
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,0.4892063023893376
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.5038464525641085
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.6443768684882512,0.4821926688112495
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,0.4897966594228012
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.6549752791632087,0.5042990924544565
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,0.4976072621090193
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.4973255869081408
FSO2013_Ratio M/L normalized Rep2,,0.5023862505332076
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.6502890147688721,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.5002313911284916
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.5044648872485077
DL2023_control-1,,
AR2021_ALG 10 μM,,0.4866443906473264
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.4989853883527195
EJN2021_4_Rest_Ins,,0.5007060788530533
RN2012_H05,,0.5206434139326004
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.4757586113266596
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,0.5013569873953876
HH2022_Reporter intensity 3,0.6338738322339834,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.4917785043114742
JW2021_After_3,,
GF2025_P8_Sph,,0.5040479131234966
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,0.49715067137112307
AH2018_SILAC_2_N,,0.49138440223988367
CK2022_11 200-1,,0.49964416907224574
CK2022_12 200-1,,0.4998865718987326
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.6920570029243259,
WZ2023_Su_010_20min,0.6481250526468206,0.526750055426907
AH2018_TMTMS2_2_N,,0.5100483496221828
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,0.4936676156296487
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.6508144112837774,0.5041472038029504
AH2018_TMTMS3_Pool,,0.4978286748935234
KS2014_Intensity N4,,0.4962574739280519
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.49689096189729276
CK2022_14 200-1,,0.4982213417593943
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.5049208772684631
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,0.5006858478295184
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.4946978217250777
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,0.4952360246737666
GF2025_P1_Sph,,0.5166210314005323
EJN2021_5_Ex_Basal,,0.49647838978181663
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.6461861825101459,0.5267115568721121
CF2017_EOC 1,,0.5034961828126724
CK2022_3 200-1,,0.5004198578030751
AH2018_LFQ_IT_3_C,,0.49399760225257866
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,0.49764206074170464
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.5001943379077619
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,,0.4907375816705546
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,0.49667001889061363
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,0.5100680592925685
CR2017_Ratio Replicate 3.2,,0.5016838466058012
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.4840092610660012
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.49832187938693134
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.49920732712672544
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.6505773701097771,0.5310230811701715
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,0.4920157780719247
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.49154493729800014
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,0.5006194085099706
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,0.49948770111312957
AH2018_LFQ_M_1_N,,0.5029383693523505
KBE2022_Log2_Ex_27_U,,0.4912754604345146
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.5045586272588922
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,0.525302470961227
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.48228996875941194
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,0.5003006528736423
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,0.4992603307212085
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5146218035036672
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.4988755370405273
HH2022_Reporter intensity 6,0.6620283382770163,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.5094765786210574
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.5084632571712661
GF2025_P3_Adh,,0.47616426665408973
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,0.5069750167005135
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.5407414652343825
KBE2022_Log2_Ex_19_U,,0.498778869316165
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,0.48799470964493996
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,0.4915916349124485
YA2020_Reporter_intensity_Cancer_No.1,,0.5112470324810122
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,0.5177399378106563
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),0.6487886727594604,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,0.5052976941184245
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5022768667893746
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,0.5113078620662558
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.49680285165828036
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,0.518756601858598
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.49432845923119323
HH2022_Reporter intensity 1,0.6307478789549308,
HH2022_Reporter intensity 2,0.6311412506830526,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.5102948680494138
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.6399007549766594,0.48055870100279635
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.49492834907578676
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.49327797480040436
AR2021_KD 72h,,0.49657421416199005
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.4947412625225888
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.5032476430060567
KBE2022_Log2_Ex_9_U,,0.48838024957621223
AH2018_SILAC_M_3_N,,0.49916463986891074
KBE2022_Log2_Ex_13_T,,0.4981503021213192
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.4939050104376744
CF2017_OSE 29,,0.49715274697505274
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,0.4956879341612212
RN2012_L12,,0.5064068352406489
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.49639592735459054
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5166026406682077
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.4930446685606212
TM2022_S2.12h.B,,
RN2012_L15,,0.5229933051401938
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.5023834205423546
FSO2013_Ratio H/M normalized Rep2___2,,0.5025756621985041
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,0.49513445222670466
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.5069553581251242
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,,0.5013013364974955
CK2022_5 200-1,,0.5014675463078168
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,0.5034866465057238
FSO2013_Ratio H/L normalized Rep2___1,,0.4810412100005617
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.4939863000935743
AH2018_SILAC_MR_1_X,,0.48902845122213384
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,0.49291885417760767
AH2018_SILAC_3_C,,0.49641072914778483
EJN2021_5_Rest_Ins,,0.4998767084925296
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.5155926810379824
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.4974701742107695
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.5040827286634878
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,0.49713794767129027
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.4993286011159632
FSO2013_Ratio H/L normalized Rep3,,0.4841010482932228
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,0.49626152447397454
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,0.4876828360619872
AH2018_SILAC_IT_2_N,,0.4933798105134533
AH2018_SILAC_IT_1_X,,0.49883443054092186
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,0.5110153399461943
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.528960639288793
WZ2023_Pe_025_20min,0.6474850305999212,0.5329996867201364
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.4931666320034573
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,,0.5104966084569413
RN2012_H06,,0.5194735633390436
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.649458382340731,0.5302139952422572
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,0.5118424485293357
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.5010858788480053
WZ2023_Su_025_10min,0.6561607249976603,0.5289820285998524
AH2018_LFQ_IT_4_X,,0.4952624224948256
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.6506569622450137,0.5345532165470258
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,0.50613044937736
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,0.4921157906934574
EP2017_Pervanadate R#1 log2 ratio,0.6639386716894408,0.5235806951694697
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,0.5089418398280343
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.4977990565965163
LY2019_P7+,,0.4948969229715295
EP2017_Untreated R#1 normalized log2 ratio,0.637395019597392,0.5236861387001915
RN2012_L10,,0.5205144640363757
PG2020_Intensity 4h_C,,0.4905241635104289
EP2017_Mitotic R#3 normalized log2 ratio,0.6408809155383594,0.4817092264500143
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,0.4942020785547636
RB2022_8_PostStrength,,0.49339345316015737
AH2018_SILAC_IT_2_X,,0.4962626176135266
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,0.5049244157361358
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,0.49003478516268406
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.506946775539558
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,0.5013123500091804
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.49841933720999254
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.647316798700246,0.4905883614918793
GF2025_P9_Sph,,0.511087051363643
CK2022_6 200-1,,0.50148691939426
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.49937897780753043
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,0.463415241592765
EP2017_Untreated R#3 normalized log2 ratio,0.6539995883727988,0.5038773328640721
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.5012456234510252
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.5042683495316927
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,0.5066408202633128
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.6639650207370944,0.5124603782128995
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,0.5058052775490524
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,0.5036225748404859
AH2018_SILAC_2_C,,0.49399131780067407
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,0.49061661951791374
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.49661448821174864
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.4921665295481053
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.5074524715921728
PG2020_Intensity CT_C,,0.49584263469103673
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,0.4956680495496614
EP2017_Untreated R#3 log2 ratio,0.6544274827573932,0.5047108074150624
RB2022_2_PostStrength,,0.49951896065143364
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.5008142459767394
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,0.4874050968900367
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.4934616773320461
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,0.5009987702965001
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.48008089643743634
YA2020_Reporter_intensity_Normal_No.2,,0.520149468992681
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.4948378238488053
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.49737044705708144
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.49885010387111167
CK2022_2 16-1,,
RAM2015_Log2 B,,0.4966390636822316
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,0.5087175258617115
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.5002039760692912
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,0.4935904307521009
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,0.5116079653852722
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,0.49834915781129346
WZ2023_Su_025_30min,0.6483392769670935,0.5286022257045221
AH2018_LFQ_4_N,,0.493762080266152
CR2017_Ratio Replicate 1.2,,0.5015492920496867
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.6679938529971895,
AH2018_SILAC_M_1_X,,0.5014248640216468
RB2022_7_PreEndurance,,0.5143608532468147
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.4978295905665289
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.4965690784214854
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.5038851937386618
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,0.5064345246556535
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.4948214576132597
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.5001697628159373
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.48440788691265385
AH2018_LFQ_2_X,,0.5050860222468997
PG2020_Intensity 2h_B,,0.4931348227729218
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,0.5111571149320066
GF2025_P3_Sph,,0.4955656452678608
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.4993994052522231
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,0.5027898142587032
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.651224954784031,0.5027098318087422
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.49486715887107896
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.5034921172163601
ZQ2022_N1,,0.5261019449331865
LY2019_P6-,,0.49284683686864134
RM2024_Intensity D2-3,,
UK2020_HCM_1,,0.5128772290857451
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5268016871778538
AH2018_LFQ_3_N,,0.49740009143332026
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,0.5110109483885954
UK2020_UA_1,,0.5109128068936413
KBE2022_Log2_Ex_13_U,,0.4991378182129271
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,0.5046890529855598
JJ2018_Ratio H/L normalized pP3,,0.49170903796701565
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.48488804269346075
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,0.49456707550534174
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.6508649946225558,0.5246244088259533
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.494336908524023
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,0.5035049574402772
FSO2013_Ratio H/L normalized Rep1,,0.500843585833917
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,0.5091211295654777
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,0.5255295860375367
PG2020_Intensity 10h_D,,0.49532637377240013
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,0.5048913186293179
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.5013976279474445
EP2017_Pervanadate R#3 log2 ratio,0.6653756586798546,0.5180633395751318
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,0.488390292039313
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.4953062334468125
AH2018_LFQ_M_4_C,,0.49574179562221254
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,0.5062024329011626
RN2012_H04,,0.5194020397245348
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,0.4921444341720495
LY2019_P3-,,0.4933954958286835
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,0.5005854210968611
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.6476321991820199,0.5234688575082892
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,0.4981869848214635
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.4927235386576763
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.6520774556793502,0.5303126148648284
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.48761936655690574
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.5095235308929891
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.5036135544676136
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.5016385795592383
LY2019_P8+,,0.5029053490347483
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,0.5100621126482753
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.6511019042022317,0.5015239342879467
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.4930506877356864
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,0.4940277338719709
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.5085409702434944
LY2019_P2-,,0.47953529053404265
AH2018_LFQ_IT_1_X,,0.5006172462334145
JJ2018_Ratio H/L normalized pP3___1,,0.49068380061007616
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.6452331189436994,0.5253124674354986
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,0.500948100018184
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.5009548549070141
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.4956156779770688
AH2018_TMTMS3_3_N,,0.5042568009766674
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.4970916553975369
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.6383891733547917,0.47558075011113815
KBE2022_Log2_Ex_36_T,,0.49413199662069296
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.649272916359763,0.5347172500161654
KS2014_Intensity C2,,0.5017665852803513
FSO2013_Ratio H/L normalized Rep1___2,,0.5069171897805226
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,0.4916077118459876
CK2022_9 200-1,,0.4998991157240689
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.49952113010361954
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,0.4997731821857463
LY2019_P1-,,0.4986392672855644
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.502394448942712
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,0.5066846984428767
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.5099578207782062
ZQ2022_C3,,0.4739562814699192
EJN2021_3_Rest_Ins,,0.5025879946890924
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.49481060464079546
FSO2013_Ratio H/M normalized Rep3___2,,0.5037134628486892
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.6376144786800798,0.5244922201880177
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.6538720486733333,0.5265171986017629
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,,0.49466341820558063
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.49994673940103435
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,0.5005378611810282
JJ2018_Ratio H/M normalized pP3,,0.49375695585379864
AH2018_SILAC_MR_2_C,,0.49331056962437075
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,0.4866360256567656
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.4956838593693959
JJ2018_Ratio H/M normalized___1,,0.49783558034008707
RCJD2014_15min_2,,0.5110365739500202
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.5308213118215381
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,,0.49305724147676955
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.6453422877751639,0.5220790200504867
KBE2022_Log2_Ex_29_U,,0.49137237976925324
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.4995819899284717
AH2018_LFQ_IT_4_N,,0.4979741207249025
CK2022_15 200-1,,0.49816417798374096
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,0.4978724309602193
JJ2018_Ratio M/L normalized pP3___1,,0.49813566414645644
KBE2022_Log2_Ex_34_T,,0.4936136117425465
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,0.4874722298547532
LY2019_P2+,,0.48776117892394044
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.4998496005465409
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6482042711214644,0.5257178438842568
RN2012_H01,,0.5209582238845026
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.4979346673422265
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.6638820344136244,0.5238108884180429
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,0.5075582806679516
KBE2022_Log2_Ex_44_U,,0.4893662194588733
WZ2023_Pe_010_20min,0.6432971370747189,0.5220168396330352
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,0.49714245674297436
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),0.6504215228951825,
RCJD2014_10min_mean,,0.5025095458091376
KS2014_Intensity C1,,0.5053150650807586
FSO2013_Ratio H/M normalized Rep3___1,,0.4935771572120214
AH2018_SILAC_M_3_C,,0.49800571985915565
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.495342305805412
AH2018_SILAC_M_2_X,,0.4914572344863159
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,0.49205784642786626
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.6477556988452193,0.5255979623765185
PG2020_Intensity 6h_C,,0.4996787878678644
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5032403240893988
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.5081643318496359
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,0.5239411957703614
FSO2013_Ratio H/L normalized Rep3___2,,0.5058130332965948
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.4903343341735991
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5097606959291042
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.6456762078536612,0.5005075057686762
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,0.512562526478417
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.6441900318473508,0.48213570471399986
EJN2021_2_Ex_Basal,,0.4948261454105314
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,0.5103884344349335
CF2017_FTE 16,,0.5043218749832794
AR2021_L41 10 μM,,0.47136604266842475
CF2017_EOC 2,,0.4997129986277195
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.5039106492791147
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,0.5107398040288528
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,0.5262369442028775
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.6309795658630345,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.5078911853435539
AR2021_L41 1 μM,,0.500615466042256
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.5088650674112138
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.5239449032406086
KS2014_Intensity C4,,0.5102593798688274
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.49372193020217253
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,0.5031395927372908
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.49905878309084534
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,0.5068429750610254
YA2020_Reporter_intensity_Cancer_No.2,,0.5062385222393571
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,0.49320161403070983
WZ2023_Pu_025_10min,0.6554292236778835,0.5347375469428818
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,0.4959931672970346
FSO2013_Ratio M/L normalized Rep3___1,,0.5173439391639442
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.49346681503231643
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.6426397740089963,0.5239280072898639
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.4913823609408065
KS2014_Intensity C6,,0.5028563333252783
ZQ2022_N3,,0.536058177337354
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.5258704040696697
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,,0.4897826421237544
CK2022_5 40-1,,
AH2018_LFQ_3_X,,0.4972640271800321
UK2020_UA_3,,0.5107335827405578
LY2019_P7-,,0.49234724136663716
GF2025_P5_Adh,,0.49473934901353234
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.4841623818832441
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,0.5102436159910414
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,0.472244557823712
CR2017_Ratio Replicate 2.1,,0.5088113113921267
PG2020_Intensity CT_B,,0.49395604822657807
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.5003482575249353
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),0.6451313504182715,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,0.5069837731614303
AH2018_LFQ_3_C,,0.4962279667129062
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5035818352738112
YA2020_Reporter_intensity_Cancer_No.4,,0.5096852719946238
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.4963821309881111
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,0.4922219698513915
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,0.49617233791895693
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,0.5008755837636635
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,0.5036390355170584
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),0.648430812869739,0.500548751637465
EP2017_Mitotic R#2 log2 ratio,0.6402541668468499,0.47800781682459714
AH2018_TMTMS2_1_X,,0.5094140972286636
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.4985893093762243
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,0.6444964573647806,
RBK2021_1326T Late,,0.5060529160656706
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,0.5083433250329193
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.5070835779198745
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,0.500607409448231
PG2020_Intensity 10h_B,,0.493536862226055
AH2018_TMTMS3_1_X,,0.5041566095947073
CF2017_FTE 14,,0.5017557251231073
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,0.5116582618731946
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.5017809740048714
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,0.4985265738522251
EP2017_Untreated R#2 normalized log2 ratio,0.6396680897984284,0.48007674358917907
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.5141323161233075
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.6640652726736339,0.512291324031699
AS2011_Ratio H/L Normalized RNAi_2_1,,
